Trust SmartSignals Solutions to Advance Type 2 Diabetes Research Date Published: Mar 03, 2021 Video Signant’s SmartSignals solutions simplify and accelerate clinical research processes. With our digital solutions, you’ll be able to validate both primary and secondary endpoints, make informed decisions, and advance diabetes treatments. Consider the solutions below for your next diabetes study: eCOA eDiary Blood glucose meters Patient Concierge Each solution accommodates all ages and abilities. Improve the clinical trial experience for your diabetes patients with Signant’s SmartSignals solutions and services. Share: LinkedInTweet Recommended Resources Type 2 Diabetes Solutions Overview Download Now Brochure Biotech Better: Solutions for Emerging Biotech/Biopharma Trials Download Now Brochure Article Optimal COA Measurement Strategy in Modern Oncology Trials The inclusion of patient-reported outcomes (PRO) data in oncology medication labeling in the U.S. has been comparatively limited. Recent FDA... Read Now